Indefinite Delivery Contract SPE2DX22D0099

The Defense Logistics Agency awarded a single-award Indefinite Delivery Contract to Amerisourcebergen Drug Corp on December 17, 2022. With a potential value of $9.999 billion and a period of performance through December 31, 2031, this contract will support the Defense Health Agency's TRICARE Pharmacy Program. Amerisourcebergen will replenish pharmaceutical and related products to multiple TRICARE pharmacy ordering facilities, provide readiness support and backup to CONUS pharmaceutical prime vendors, and integrate with the TRICARE Pharmacy Program 5 contract. This contract aims to procure pharmaceutical distribution services to TRICARE beneficiaries, as outlined in the National Prime Vendor Generation IV draft Statement of Work originally solicited in June 2020.

The originating solicitation sought industry feedback to support the Defense Health Agency's TRICARE Pharmacy Program, with the National Prime Vendor intended to replenish ordering facilities associated with the TRICARE Mail Order Pharmacy and TRICARE Specialty Pharmacy Network. Pricing would consist of Federal Supply Schedule, DAPA, or regional DAPA prices plus the contractor's distribution fee and Cost Recovery Rate. No set-asides were applied. The awarded contract supports these goals of procuring pharmaceutical logistics to service military treatment facilities and TRICARE beneficiaries.